These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopaminergic-based pharmacotherapies for depression. Papakostas GI Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172 [TBL] [Abstract][Full Text] [Related]
4. New approaches to antidepressant drug discovery: beyond monoamines. Berton O; Nestler EJ Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123 [TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for major depressive disorder. Connolly KR; Thase ME Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643 [TBL] [Abstract][Full Text] [Related]
6. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Nishtala PS; McLachlan AJ; Bell JS; Chen TF Am J Geriatr Pharmacother; 2009 Aug; 7(4):210-9. PubMed ID: 19766953 [TBL] [Abstract][Full Text] [Related]
7. Phosducin-like protein levels in leukocytes of patients with major depression and in rat cortex: the effect of chronic treatment with antidepressants. Matuzany-Ruban A; Schreiber G; Farkash P; Avissar S Psychiatry Res; 2006 Mar; 141(3):287-94. PubMed ID: 16510194 [TBL] [Abstract][Full Text] [Related]
8. A role for AMPA receptors in mood disorders. Alt A; Nisenbaum ES; Bleakman D; Witkin JM Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080 [TBL] [Abstract][Full Text] [Related]
9. Is duloxetine effective treatment for depression with atypical features? Stewart JW; Deliyannides DA; McGrath PJ Int Clin Psychopharmacol; 2008 Nov; 23(6):333-6. PubMed ID: 18854721 [TBL] [Abstract][Full Text] [Related]
10. Emerging role of glutamate in the pathophysiology of major depressive disorder. Hashimoto K Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572 [TBL] [Abstract][Full Text] [Related]
11. Emerging treatments for major depression. Norman TR; Burrows GD Expert Rev Neurother; 2007 Feb; 7(2):203-13. PubMed ID: 17286553 [TBL] [Abstract][Full Text] [Related]
12. The role of CREB in depression and antidepressant treatment. Blendy JA Biol Psychiatry; 2006 Jun; 59(12):1144-50. PubMed ID: 16457782 [TBL] [Abstract][Full Text] [Related]
13. [Glutamatergic neurotransmission, depression and antidepressants]. Ferrero A; Cereseto M Vertex; 2004; 15(56):91-8. PubMed ID: 15243652 [TBL] [Abstract][Full Text] [Related]
14. New approaches to the pharmacological management of major depressive disorder. Witkin JM; Li X Adv Pharmacol; 2009; 57():347-79. PubMed ID: 20230766 [TBL] [Abstract][Full Text] [Related]
15. Strategies for switching antidepressants to achieve maximum efficacy adolescents. Jefferson JW J Clin Psychiatry; 2008; 69 Suppl E1():14-8. PubMed ID: 18494539 [TBL] [Abstract][Full Text] [Related]
16. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961 [TBL] [Abstract][Full Text] [Related]